
On Friday, April 7, federal judges in both Texas and Washington state issued contradictory rulings on the abortion pill mifepristone.
Federal judge Matthew Kacsmaryk of the Northern District of Texas ruled that the FDA improperly approved mifepristone and ordered the agency to remove mifepristone from the market by April 14. One hour later, fellow federal judge Thomas O. Rice in the Eastern District of Washington issued an injunction blocking the FDA from “altering the status quo and rights as it relates to the availability of mifepristone.”